Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors. (2022)
Attributed to:
Functional characterisation of a novel BRCA1-mRNA splicing complex that is mutated in multiple cancers.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-21-1843
PubMed Identifier: 35027467
Publication URI: http://europepmc.org/abstract/MED/35027467
Type: Journal Article/Review
Volume: 82
Parent Publication: Cancer research
Issue: 5
ISSN: 0008-5472